[Abstract] MHC class I molecules present peptides to cytotoxic T cells allowing the immune system to scan for intracellular pathogens and mutated proteins. The generation of antigenic peptides is a multistep process that ends in the endoplasmic reticulum (ER). Only peptides with the right length and sequence will bind nascent MHC class I molecules in the ER. This protocol allows for detachment of the endogenous peptides bound to MHC class I molecules by preserving them for the binding of high affinity synthetic peptides. The complete dissociation of endogenous peptides by mild acid treatment as well as the binding of synthetic peptides to MHC class I molecules will be evaluated measuring HLA class I molecules express on the cell surface by flow cytometry. The mouse antibody W6/32 which recognizes β2m associated HLA-A, -B, -C, -E and -G heavy chains is suitable for this propose. Any tumor cell line that expresses surface HLA class I molecules is suitable for the assay. Another important aspect is to know the HLA class I typing of tumor cell line to allow selection of the known high affinity peptides.
endogenous peptides bound to MHC class I molecules by preserving them for the binding of high affinity synthetic peptides. The complete dissociation of endogenous peptides by mild acid treatment as well as the binding of synthetic peptides to MHC class I molecules will be evaluated measuring HLA class I molecules express on the cell surface by flow cytometry. The mouse antibody W6/32 which recognizes β2m associated HLA-A, -B, -C, -E and -G heavy chains is suitable for this propose. Any tumor cell line that expresses surface HLA class I molecules is suitable for the assay. Another important aspect is to know the HLA class I typing of tumor cell line to allow selection of the known high affinity peptides. 1. Tumor cells are cultured in fresh RPMI medium at a cell density ≥ 0.5-2 x 10 6 cell/ml depending on the type of cells, in an incubator at 37 °C, 5% CO2.
Materials and Reagents
2. Wash adherent cells in PBS (5 ml) and detach cells by adding 833 μM EDTA (1 ml for T25 flask and 2 ml for T75 flask) for 3-5 min in an incubator at 37 °C, 5% CO2.
3. Wash cells twice with PBS (2 x 5 ml in 15 ml tube) by centrifugation at 468 x g for 7 min and resuspend them in cold FACS buffer.
4. Count total viable cells with Trypan-Blue exclusion method.
5. Harvest 5-10 x 10 6 cells with 5 ml PBS (at RT) in 15 ml tubes.
6. Centrifuge cells at 468 x g for 7 min.
7. Discard the supernatant and re-suspend the cells in 600 μl cold acid buffer by manual gentle shaking. viability; the complete dissociation will be deduced with the cell surface expression of HLA class I molecules detected by staining the cells with the mAb W6/32).
9. Immediately add 10 ml of complete RPMI (at RT).
10. Centrifuge cells at 468 x g for 7 min.
11. Discard supernatant and re-suspend the cells in 10 ml of complete RPMI.
12. Centrifuge cells at 468 x g for 7 min.
13. Discard supernatant and re-suspend the cells in 1 ml of complete RPMI containing beta 2-microglobulin (5 μg/ml).
B. Pulsing with peptides 1. Seed the cells in 6 well plate at a cell density of 1 x 10 6 cells/well. Prepare 1 well for the control (without peptide) and 1 well for each peptide to be tested and/or a mix of different peptides.
2. Add 50 μM of peptide (stocked at 10 mM, single or a mix of different peptides).
3. Incubate for 2 h at RT and for additional 2 h at 37 °C in an incubator.
C. Staining and FACS analysis
1. Harvest cells in 1.5 ml Safe-Lock tubes and centrifuge at 468 x g for 7 min.
2. Discard the supernatant and re-suspend the cells in 100 μl of cold FACS buffer.
3. Distribute in a round-bottom 96 well plate (50 μl/well). 12. Acquire data using DIVA software and analyse using FlowJo software.
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